HEALTH SCIENCE IPOS: WILL WE CONTINUE TO BREAK RECORDS?

It’s never too early to think about planning your company’s exit. Join OBIO for a discussion with health science CEOs, investors, and financial experts with experience in the US and Canadian public markets. Hear their IPO lessons learned, learn about the routes and vehicles for accessing public markets, the pros and cons, and important considerations every CEO should know before taking their company public.